NCT02280382 - An Intervention to Improve Prolapse Using Femmeze® (v1) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

March 31, 2019

Conditions

RectocelePelvic Organ Prolapse

Interventions

DEVICE

Femmeze®

Femmeze will be used by women in the intervention group for 8 weeks These women will be measuring against their usual care in a linear design; measurement will include validated questionnaires

Trial Locations (1)

TR1 3JL

RoyalCornwallHT, Truro